Testing the campaign was helpful for us since we received many suggestions from the participants that have helped us shape the final idea, while we also got positive feedback from the focus groups. The correct approach to the campaign was also confirmed by the positive results of measuring the effects of the campaign with AdDiagnosticon.
Initially, the study was deemed as a cost, but we consider it a very good investment. It clarified our assumptions and helped us understand why we are not achieving the expected sales results. We immediately implemented optimizations and positive results are already evident.
Before the launch of our new regional corporate campaign, we used the new EEG method to review the attention and emotional response to our TV ad.
As a result we were able to optimize the ad and thus achieved higher empathy, which is essential for successful corporate communication.
HT is among the first companies to recognize the values of neurophysiological measurements of the effectiveness of advertising campaigns through Valicon Neuro.Diagnosticon. In addition to helping gaining user attention and increase in effectiveness of messages in specific campaigns, we have also gained over the years very specific know-how that we can apply in creating future campaigns. It is unanimous evaluation that Neuro.Diagnosticon has made a significant contribution in increasing the attractiveness and effectiveness of the HT campaigns in B2C and in the B2B segment in the last two years. Valicon has proved to be a valuable and reliable HT partner in the field of customer insight.
Consumer data 
Analytics and Prediction 
Custom made solutions 
Strategic consulting